Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Double Downgrade: Abbott India Share Price Target, Rating Slashed On Weak Growth Outlook

    1 week ago

    Competitive pressures, particularly from global players like Novo Nordisk, are intensifying, especially with the transition toward next-generation diabetes therapies, like GLP-1.
    Click here to Read More
    Previous Article
    Vishal Mega Mart Shares In Focus As HDFC Securities Initiates 'Buy' Coverage — Check Target Price
    Next Article
    New Employee Resigns Within A Week Over Toxic Behaviour, Accuses HR Of Denying Wages

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment